OR WAIT null SECS
Jill Wechsler is Pharmaceutical Technology's Washington Editor, jillwechsler7@gmail.com.
January 28, 2015
Industry voices concerns over draft legislation that seeks to get much needed treatments to patients.
January 23, 2015
Government and industry efforts to address manufacturing challenges move Ebola vaccine candidates into larger clinical trials.
January 20, 2015
FDA aims is to collect data regularly from manufacturers that will indicate the ability of a firm and its facilities to produce high-quality therapies on a continual, error-free basis.
January 08, 2015
An FDA expert committee has recommend approval of Zarizio, the first US biosimilar application from Sandoz, setting a milestone for generic biologic drugs and setting the stage for future approvals.
January 05, 2015
FDA’s Center for Drug Evaluation and Research implements its reorganization to bolster programs and policies to ensure drug with its “super” Office of Pharmaceutical Quality (OPQ).
January 02, 2015
Manufacturers are under pressure to develop pipelines, promote quality, and justify pricing.